Charles Cherington, 10% Owner at Comera Life Sciences (NASDAQ:CMRA), reported a large insider buy on September 12, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Cherington purchased 2,053,789 shares of Comera Life Sciences. The total transaction amounted to $1,049,896.
Comera Life Sciences shares are trading up 21.65% at $0.41 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily ...